Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations

This pharmacoepidemiology study uses Medicaid data to estimate associations between first-trimester use of intravenous ondansetron and risk of cardiac malformations and oral cleft in children of exposed mothers.

Saved in:
Bibliographic Details
Published in:JAMA
Main Authors: Huybrechts, Krista F., Hernandez-Diaz, Sonia, Straub, Loreen, Gray, Kathryn J., Zhu, Yanmin, Mogun, Helen, Bateman, Brian T.
Format: Artigo
Language:Inglês
Published: American Medical Association 2020
Subjects:
Research Letter
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6865841/
https://ncbi.nlm.nih.gov/pubmed/31730152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.18587
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items